Abstract
When intact cells (HeLa S-3, mouse 3T3 flbroblasts, hen erythrocytes) are incubated with the rifamycin SV derivative AF/013, which is widely used as a potent inhibitor of mammalian DNA-dependent RNA polymerases, a rapid and extensive disintegration of the plasma membrane takes place. This cell disruption results, for example, in hemolysis of the erythrocytes at concentrations above 50 µg/ml, in the release of cytoplasmic components, including ribosomes, and in dramatic ultrastructural changes in the HeLa and mouse 3T3 cells. In HeLa cells incubated for 30 min in 100 µ/ml of the drug, about 70% of the RNA, 44% of the protein, and 26% of the phospholipids leak out into the medium. The permeability of the plasma membrane is markedly increased, even at relatively low AF/013 concentrations. In the presence of 20 µg/ml of the drug, for example, 70% of the trichloracetic acid-soluble radioactivity and 10% of the trichloracetic acid-precipitable RNA are released from [3H]uridine-labeled HeLa cells. The membranolytic action of AF/013 is higher than that of the nonionic surfactant Triton X-100. This high toxicity indicates that AF/013 cannot be used as a specific inhibitor of RNA polymerases in vivo.
ACKNOWLEDGMENTS I thank Mrs. Erika Schmid, Miss Stephanie Winter, and Miss Marianne Winter for excellent technical assistance; Mr. W. Rubik (Institute of Biochemistry, German Cancer Research Center, Heidelberg), for the mass spectroscopic analysis; as well as Drs. W. W. Franke and H. Zentgraf, for helpful discussions.
- Copyright ©, 1975, by Academic Press, Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|